Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Biostatistics: Overview

Biostatistics: Overview

Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study.

Alzheimer's & dementia (New York, N. Y.)·2026

Same author

A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study.

bioRxiv : the preprint server for biology·2026

Same author

Robust Bayesian multilevel meta-analysis: Adjusting for publication bias in the presence of dependent effect sizes.

Behavior research methods·2026

Same author

Evaluating the Duke Iterative Cognitive Examination Against the Montreal Cognitive Assessment: Validity and Clinical Utility.

Neurology. Clinical practice·2026

Same author

Diffusion weighted imaging abnormalities and cerebral ischemia in a cohort of patients on lecanemab.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Integrated metabolomics and proteomics from voxelated cortical hemispheres of adult rhesus monkeys.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: Oct 1, 2025

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

A Bayesian perspective on Biogen's aducanumab trial.

Anna G M Temp^1,2, Alexander Ly^3,4, Johnny van Doorn³

¹German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association

|March 2, 2022

Summary

Bayesian analysis offers advantages for clinical trials, quantifying evidence for or against an effect. This contrasts with traditional frequentist tests, providing a more nuanced understanding of Alzheimer's disease drug efficacy.

Keywords:

Alzheimer's disease Bayesian statistics aducanumab clinical trials

More Related Videos

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Related Experiment Videos

Last Updated: Oct 1, 2025

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Area of Science:

Clinical Research
Biostatistics
Neuroscience

Background:

Traditional frequentist statistical methods in clinical research often yield binary conclusions.
Bayesian inference presents an alternative approach to statistical analysis.
The use of Bayesian analysis in clinical trials requires clear explanation and demonstration.

Purpose of the Study:

To introduce and highlight the relevance and advantages of Bayesian inference in clinical trials.
To apply Bayesian analysis to real-world clinical trial data as an illustrative example.
To contrast Bayesian methods with frequentist approaches in interpreting trial results.

Main Methods:

Bayesian analysis of model plausibility and effect sizes.
Application to simulated data from two Phase 3 trials of aducanumab.
Utilizing data presented at a Food and Drug Administration hearing for Alzheimer's disease (AD).

Main Results:

Bayesian analysis quantifies evidence for or against an effect, offering 'evidence of absence'.
It assesses the strength of observed effects.
Demonstrates a more nuanced interpretation compared to binary frequentist outcomes.

Conclusions:

Bayesian inference provides valuable tools for clinical trial analysis, offering richer insights than frequentist methods.
The application to aducanumab data illustrates the practical benefits of this approach in Alzheimer's disease research.
Bayesian methods enhance the interpretation of clinical trial evidence, particularly in complex cases.